CN105326040A - Microelement nutrient tablet for preventing and nursing myopia and computer vision syndrome - Google Patents
Microelement nutrient tablet for preventing and nursing myopia and computer vision syndrome Download PDFInfo
- Publication number
- CN105326040A CN105326040A CN201510768120.0A CN201510768120A CN105326040A CN 105326040 A CN105326040 A CN 105326040A CN 201510768120 A CN201510768120 A CN 201510768120A CN 105326040 A CN105326040 A CN 105326040A
- Authority
- CN
- China
- Prior art keywords
- computer vision
- myopia
- vision syndrome
- preventing
- micro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 18
- 206010068906 Computer vision syndrome Diseases 0.000 title claims abstract description 17
- 230000004379 myopia Effects 0.000 title claims abstract description 13
- 208000001491 myopia Diseases 0.000 title claims abstract description 13
- 230000000474 nursing effect Effects 0.000 title claims abstract description 4
- 239000000843 powder Substances 0.000 claims abstract description 11
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 6
- 235000013336 milk Nutrition 0.000 claims abstract description 6
- 239000008267 milk Substances 0.000 claims abstract description 6
- 210000004080 milk Anatomy 0.000 claims abstract description 6
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 5
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 5
- 239000006071 cream Substances 0.000 claims abstract description 5
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 22
- 235000016709 nutrition Nutrition 0.000 claims description 20
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 20
- 239000011573 trace mineral Substances 0.000 claims description 15
- 235000013619 trace mineral Nutrition 0.000 claims description 15
- 229930003427 Vitamin E Natural products 0.000 claims description 11
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 11
- 235000019165 vitamin E Nutrition 0.000 claims description 11
- 229940046009 vitamin E Drugs 0.000 claims description 11
- 239000011709 vitamin E Substances 0.000 claims description 11
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims description 10
- 102000006587 Glutathione peroxidase Human genes 0.000 claims description 10
- 108700016172 Glutathione peroxidases Proteins 0.000 claims description 10
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 10
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims description 10
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims description 10
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims description 10
- 235000012680 lutein Nutrition 0.000 claims description 10
- 239000001656 lutein Substances 0.000 claims description 10
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 10
- 229960005375 lutein Drugs 0.000 claims description 10
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 10
- 229920001542 oligosaccharide Polymers 0.000 claims description 10
- 150000002482 oligosaccharides Chemical class 0.000 claims description 10
- 239000011669 selenium Substances 0.000 claims description 10
- 229910052711 selenium Inorganic materials 0.000 claims description 10
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 10
- 235000010930 zeaxanthin Nutrition 0.000 claims description 10
- 239000001775 zeaxanthin Substances 0.000 claims description 10
- 229940043269 zeaxanthin Drugs 0.000 claims description 10
- 235000013399 edible fruits Nutrition 0.000 claims description 8
- 230000035764 nutrition Effects 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 5
- 239000005862 Whey Substances 0.000 claims description 4
- 230000003750 conditioning effect Effects 0.000 claims description 4
- 230000036541 health Effects 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 9
- 102000004169 proteins and genes Human genes 0.000 abstract description 7
- 108090000623 proteins and genes Proteins 0.000 abstract description 7
- 210000000056 organ Anatomy 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 abstract 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N keto-D-fructose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 235000021119 whey protein Nutrition 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 201000009487 Amblyopia Diseases 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 208000028571 Occupational disease Diseases 0.000 description 2
- 208000034700 Vitreous opacities Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000003464 asthenopia Diseases 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 206010023332 keratitis Diseases 0.000 description 2
- 208000002780 macular degeneration Diseases 0.000 description 2
- 208000001749 optic atrophy Diseases 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 208000005494 xerophthalmia Diseases 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000004344 low myopia Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000199 molecular distillation Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 description 1
- 230000004436 pseudomyopia Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to a microelement nutrient tablet for preventing and nursing myopia and a computer vision syndrome. The microelement nutrient tablet is prepared from, by weight, fresh milk, whey protein powder, milk sugar, cream, white granulated sugar, fruit powder and nutrimental microelements. According to the microelement nutrient tablet, when integrated, seven nutrients are shown in the biological active peptide and protein peptide form, become functional nutrients and are superior to high protein, various nutrient substances eaten by a person are carried and delivered to cells, tissues and organs of the human body.
Description
Technical field
The present invention relates to a kind of nutrient drug nursing one's health eyesight, particularly relate to a kind of micro-element nutrition sheet preventing to nurse one's health myopia and computer vision syndrome.
Background technology
Disease, the children such as computer vision syndrome comprises tired out, ghost image, blurred vision, sheds tears, has a headache, dizziness, neck pain then change formal myopia by pseudo-myopia, low myopia, early stage myopia.Western developed country computer vision syndrome, is classified as occupational disease, and United States Medical Doctor Amire is classified as computer vision syndrome as 21 century the most serious occupational disease.Computer vision syndrome has become the disease kind of a large class uniqueness, a kind of novel common disease frequently-occurring disease.This new pathogeny, ciril disease, itself is not fearful, and fearful is that its popularity rate is high, and morbidity starts with children.
Computer vision syndrome, although non-world-famous puzzle, but medical circle solves weak also till now, and Present Domestic treats computer vision syndrome outward, only rests on the protection stage.
Summary of the invention
The present invention is directed to above-mentioned problems of the prior art, provide a kind of micro-element nutrition sheet preventing to nurse one's health myopia and computer vision syndrome, solve the problem in prior art, computer vision syndrome only being rested on to the protection stage.
Technical scheme of the present invention is as follows:
It is prepared from by following raw materials by weight portion ratio, fresh milk: PURE WHEY: lactose: cream: white granulated sugar: fruit powder: nutritional trace element=10000:20:15:10:10:5:10.
Described nutritional trace element is prepared from by ratio of weight and the number of copies by following nutrient, glutathione peroxidase: lutein: zeaxanthin: carrotene: Organic Selenium: oligosaccharides: vitamin E=10-20:15-30:10-20:15-25:5-15:10-20:3-8.
The preferred weight portion rate of described nutritional trace element is, glutathione peroxidase: lutein: zeaxanthin: carrotene: Organic Selenium: oligosaccharides: vitamin E=15:20:15:20:10:15:5.
Described fruit powder is Smallantus sonchifolium fruit powder.
Advantageous effect of the present invention is as follows: when seven taste nutrients are integrated, occur with the appearance of biologically active peptide, protein peptides, become functional nutrient element, be better than high protein, peptide is not high protein, but be a kind of functional protein, peptide can transmission of information in human body, and overload body effect, eats various nutriment by people, as vitamin, biotin, trace element etc., deliver and be transported in each cell of human body, tissue and organ and go.
Peptide is higher than amino acid by 26% at human body synthetic protein ratio, amino acid whose mechanism of absorption, only has synthetic peptide just can be absorbed by the body.There is layer protecting film on biologically active peptide surface; the hydrolysis of the short enzyme of human body, pepsin, pancreatin, amylase, digestive ferment, digestive ferment and acid-base material secondary can not be subject to; it directly enters small intestine with complete form, is entered human recycle system by intestinal absorption, plays its function.Nutrients Absorption of the present invention is fast especially, enters the circulatory system as intravenous injection, can play a role very soon, it has 100% absorption characteristics, without any waste discharge during absorption, is all utilized by human body, active absorption, does not consume body energy, can not increase gastrointestinal function burden.Effective reparation cataract, vitreous opacity, macular degeneration disease, optic atrophy, keratitis, eye are dry and astringent, the healing of xerophthalmia, myopia, amblyopia, postoperative wound, alleviating asthenopia, prevention eyes are aging, cause various eye illnesses etc. by diabetes.
Glutathione of the present invention, lutein, oligosaccharides, vitamin E, carotene, zeaxanthin, Organic Selenium and glutathione peroxidase, their mutual Synergistics, incidentally remove the cancer cell of whole body, diseases prevention is in possible trouble.
Detailed description of the invention
embodiment 1
It is prepared from by following raw materials by weight portion ratio, fresh milk: PURE WHEY: lactose: cream: white granulated sugar: Smallantus sonchifolium fruit powder: nutritional trace element=10000:20:15:10:10:5:10.
The preferred weight portion rate of described nutritional trace element is, glutathione peroxidase: lutein: zeaxanthin: carrotene: Organic Selenium: oligosaccharides: vitamin E=15:20:15:20:10:15:5.
Molecular distillation technique is utilized to extract vitamin E, nutrition raw material for standby required for classification extraction, containing trace element 100 grams in every 100 jin of nutrient tablet raw materials, trace element is prepared from by glutathione peroxidase 15 grams, 20 grams, lutein, zeaxanthin 15 grams, carrotene 20 grams, Organic Selenium 10 grams, oligosaccharides 15 grams, vitamin E 5 grams.By the sterilization of 200 jin of fresh milk buses, add PURE WHEY 200 grams, lactose 150 grams, 100 grams, cream, white granulated sugar 100 grams, Smallantus sonchifolium fruit 50 grams, powder, add above-mentioned nutritional trace element 100 grams, through mixing, homogeneous, concentrated, spraying, that original washing powder mixed pressuring plate packaging is made in drying is obtained.Nutrient tablet, candy sheet, milk sheet, chewing gum etc. can be made into.
Embodiment 2
Described nutritional trace element is prepared from by ratio of weight and the number of copies by following nutrient, glutathione peroxidase: lutein: zeaxanthin: carrotene: Organic Selenium: oligosaccharides: vitamin E=10:15:10:15:5:10:3.The other the same as in Example 1.
Embodiment 3
Described nutritional trace element is prepared from by ratio of weight and the number of copies by following nutrient, glutathione peroxidase: lutein: zeaxanthin: carrotene: Organic Selenium: oligosaccharides: vitamin E=20:30:20:25:15:20:8.The other the same as in Example 1.
Embodiment 4
Described nutritional trace element is prepared from by ratio of weight and the number of copies by following nutrient, glutathione peroxidase: lutein: zeaxanthin: carrotene: Organic Selenium: oligosaccharides: vitamin E=10:30:20:15:5:20:8.The other the same as in Example 1.
Beneficial effect of the present invention is set forth further below by way of the test of pesticide effectiveness.
One, data:
Accept for medical treatment altogether and there is computer vision syndrome 100 example, wherein the male sex 58 example, women 42 example, the oldest person 83 years old, reckling 6 years old, the most elder of symptom 2 years, the shortest person 30 days; Symptom main manifestations is, cataract, vitreous opacity, macular degeneration disease, optic atrophy, keratitis, eye are dry and astringent, the healing of xerophthalmia, myopia, amblyopia, postoperative wound, visual fatigue.
Two, consumption and method:
Oral: daily 2-3 time, each 3 grams, under plain boiled water clothes.Take one to three month continuously.
In the process for the treatment of, cut out other vision care drug.
Three, criterion of therapeutical effect and judgement:
1, efficacy criteria:
Rehabilitation: symptom disappears completely.
Effective: symptom major part disappears.
Invalid: symptom is improved not obvious.
2, result judges:
In 100 examples, rehabilitation 90 example, effective 3 examples, invalid 7 examples, total effective rate of the present invention is 93%.
Protection scope of the present invention is as the criterion with claim, not limited by specific embodiment.
Claims (4)
1. one kind is prevented the micro-element nutrition sheet nursing one's health myopia and computer vision syndrome, it is characterized in that being prepared from by following raw materials by weight portion ratio, fresh milk: PURE WHEY: lactose: cream: white granulated sugar: fruit powder: nutritional trace element=10000:20:15:10:10:5:10.
2. a kind of micro-element nutrition sheet preventing conditioning myopia and computer vision syndrome according to claim 1, it is characterized in that described nutritional trace element is prepared from by ratio of weight and the number of copies by following nutrient, glutathione peroxidase: lutein: zeaxanthin: carrotene: Organic Selenium: oligosaccharides: vitamin E=10-20:15-30:10-20:15-25:5-15:10-20:3-8.
3. a kind of micro-element nutrition sheet preventing conditioning myopia and computer vision syndrome according to claim 2, it is characterized in that the preferred weight portion rate of described nutritional trace element is, glutathione peroxidase: lutein: zeaxanthin: carrotene: Organic Selenium: oligosaccharides: vitamin E=15:20:15:20:10:15:5.
4. a kind of micro-element nutrition sheet preventing conditioning myopia and computer vision syndrome according to claim 1, is characterized in that described fruit powder is Smallantus sonchifolium fruit powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510768120.0A CN105326040A (en) | 2015-11-12 | 2015-11-12 | Microelement nutrient tablet for preventing and nursing myopia and computer vision syndrome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510768120.0A CN105326040A (en) | 2015-11-12 | 2015-11-12 | Microelement nutrient tablet for preventing and nursing myopia and computer vision syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105326040A true CN105326040A (en) | 2016-02-17 |
Family
ID=55277025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510768120.0A Pending CN105326040A (en) | 2015-11-12 | 2015-11-12 | Microelement nutrient tablet for preventing and nursing myopia and computer vision syndrome |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105326040A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070166354A1 (en) * | 2005-10-26 | 2007-07-19 | Bridget Barrett-Reis | Method of reducing the risk of retinopathy of prematurity in preterm infants |
| CN101647493A (en) * | 2008-08-14 | 2010-02-17 | 白心亮 | Lutein Chinese wolfberry blueberry eye protecting milk tablet |
| CN101766307A (en) * | 2010-03-02 | 2010-07-07 | 中国农业科学院油料作物研究所 | Health food with function of relieving visual fatigue and preparation method thereof |
| CN102077935A (en) * | 2010-09-20 | 2011-06-01 | 王强 | Marine special dietary food special for vision recession patient |
-
2015
- 2015-11-12 CN CN201510768120.0A patent/CN105326040A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070166354A1 (en) * | 2005-10-26 | 2007-07-19 | Bridget Barrett-Reis | Method of reducing the risk of retinopathy of prematurity in preterm infants |
| CN101647493A (en) * | 2008-08-14 | 2010-02-17 | 白心亮 | Lutein Chinese wolfberry blueberry eye protecting milk tablet |
| CN101766307A (en) * | 2010-03-02 | 2010-07-07 | 中国农业科学院油料作物研究所 | Health food with function of relieving visual fatigue and preparation method thereof |
| CN102077935A (en) * | 2010-09-20 | 2011-06-01 | 王强 | Marine special dietary food special for vision recession patient |
Non-Patent Citations (4)
| Title |
|---|
| 俞永珍等: "氧化应激及抗氧化物在年龄相关性黄斑变性中的作用", 《眼科新进展》 * |
| 季玉娜: "玉米护眼抗癌作用大", 《大众卫生报》 * |
| 郑建仙: "《功能性食品学 2版》", 30 June 2009, 中国轻工业出版社 * |
| 金鑫等: "缓解视疲劳功能食品及其功效成分研究进展", 《食品科学》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kumar et al. | Traditional and medicinal uses of banana | |
| ES2607230T3 (en) | Composition of dietary fiber containing beta-glucan | |
| WO2018010441A1 (en) | Chinese medicine healthcare preparations for slimming and weight loss | |
| CN100546609C (en) | The application of a kind of compositions in the cataractous medicine of preparation control | |
| CN109645201A (en) | Composition containing lutein and lutein ester, lutein pressed candy and preparation method and application | |
| CN100384451C (en) | Medicine and food dual purpose Chinese medicinal nutritive product for preventing and treating vision syndrome due to computer and its manufacturing method | |
| JP6838745B2 (en) | A method for producing fermented mineral raw food pills that have the function of improving constipation and recovery from fatigue. | |
| CN111227097A (en) | Blueberry lutein ester candy tablet and preparation method thereof | |
| CN100391503C (en) | Medicine and food dual purpose Chinese and western medicinal nutritive product for preventing and treating xeroma and its manufacturing method | |
| CN100384455C (en) | Chinese medicine and food dual purpose nutritive product for preventing and treating cornea malacia and its manufacturing method | |
| CN103263012A (en) | Edible and pharmaceutical health-care foodstuff and preparation method thereof | |
| CN1824048A (en) | Medicine and food dual purpose Chinese medicinal product for preventing and treating scheroma and its manufacturing method | |
| CN101946895B (en) | Functional food taking loach as main material and preparation method thereof | |
| CN1824042B (en) | Applicaiton of a composition for preparing medicine and food dual purpose nutritive product for preventing and treating computer vision syndrome | |
| CN101416741A (en) | Health-care food for relieving visual fatigue | |
| CN106723075A (en) | A kind of double ginseng sea-buckthorn G-protein saline cistanche zinc selenium preparations and preparation method thereof | |
| CN1824041A (en) | Medicine and food dual purpose nutritive product for preventing and treating computer vision syndrome and its manufacturing method | |
| CN103100004A (en) | Pure traditional Chinese medicine preparation infantile malnutrition pills | |
| CN105326040A (en) | Microelement nutrient tablet for preventing and nursing myopia and computer vision syndrome | |
| CN103262981A (en) | Nutritive porridge and preparation method thereof | |
| CN100506085C (en) | Brown sugar health product capable of raising immunity of puerpera | |
| CN100353972C (en) | Chinese and western medicine combined medicine and food dual purpose product for preventing and treating cornea malacia and its manufacturing method | |
| CN107753775B (en) | Chrysanthemum composition and application thereof | |
| CN101549077A (en) | Traditional Chinese medicine preparation for combined treatment of infantile diarrhea | |
| KR20150095531A (en) | Baeksan hanbang baekse geongang jumun tea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160217 |